SCHEMBL14479261

SCHEMBL14479261

Bc1nc2c(c(=O)[nH]c(=O)n2C)n1CC#CC

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
LMNA P02545 2/20 0.49
HTT P42858 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
HPGD P15428 6/20 0.48
CYP2C9 P11712 1/20 0.48
KDM4E B2RXH2 3/20 0.46
MAPK1 P28482 5/20 0.45
HSD17B10 Q99714 5/20 0.44
NPSR1 Q6W5P4 2/20 0.43
MAPT P10636 2/20 0.43
TSHR P16473 2/20 0.43
POLB P06746 1/20 0.43
BRAF P15056 1/20 0.42
GFER P55789 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17124943 0.85 HPGD (0.49) ALDH1A1SMN1; SMN2LMNAHTTTDP1
SCHEMBL554961 0.84 HPGD (0.48) ALDH1A1SMN1; SMN2LMNAHTTTDP1
SCHEMBL16392270 0.84 HPGD (0.48) ALDH1A1SMN1; SMN2LMNAHTTTDP1
SCHEMBL497538 0.84 KDM4E (0.62) ALDH1A1SMN1; SMN2LMNAHTTTDP1
SCHEMBL8266888 0.81 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2LMNAHTTTDP1
SCHEMBL5718831 0.77 DPP4 (0.71) ALDH1A1SMN1; SMN2MAPK1POLB
SCHEMBL15840964 0.76 GAA (0.57) ALDH1A1SMN1; SMN2LMNAHTTTDP1
SCHEMBL19976357 0.76 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2LMNAHTTTDP1
SCHEMBL29801249 0.74 MAPK1 (0.47) ALDH1A1SMN1; SMN2LMNAHTTTDP1
SCHEMBL29801555 0.74 MAPK1 (0.47) ALDH1A1LMNAHTTHPGDCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2540724-A1 Hydrochlorides and hydrates of 1-[(3-cyano-pyridin-2-yl) methyl]-3-methyl-7-(2-butin-1-yl)-8-(3-amino-piperidin-1-yl)-xanthi, their manufacture and use of same as medicine Boehringer Ingelheim International GmbH (DE) 2013-01-02 EP disclosed